Pomdoctor To Terminate Its ADR Program And List Its Class A Ordinary Shares Directly On The Nasdaq
The termination was previously approved by the board of directors of Pomdoctor on September 3, 2026 and approved by the Company's shareholders on a non-binding advisory basis at the extraordinary general meeting of
Pomdoctor is switching how its stock trades on Nasdaq. Instead of using a special wrapper called an ADR, people will buy shares directly, which is simpler.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.